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aBstraCt
introduCtion. The purpose of the study was to evaluate the intraocular pressure (IOP) lowering effect of lens 
removal in eyes with primary angle closure glaucoma (PACG) and primary angle closure (PAC).
MATERIALS AND METHODS. This study was a retrospective analysis of 114 eyes of 97 patients (83 women, 14 men; 
mean age 69.9 years) with PACG and PAC treated with lens extraction. Outcome measures: age, gender, visual 
acuity, IOP reduction over time, preoperative and postoperative number of IOP-lowering medications, axial length, 
intraocular lens (IOL) power, requirement for additional anti-glaucoma operations, and complications. Patients were 
divided into three groups: 1) patients with PAC (22 eyes) with mean follow-up 12.2 months; 2) patients with PACG 
with a history of previous acute angle closure (AAC) (39 eyes) with mean follow-up 15.4 months; and 3) patients 
with PACG without a history of previous AAC (53 eyes), with mean follow-up 13.5 months. Laser iridotomy was 
performed in all treated eyes prior to the surgery. 
RESULTS. In the group with PAC mean IOP was reduced from 42.2 ± 15.4 mm Hg (mean ± SD) under 
2.6 IOP-lowering medications to 20.2 ± 10.4 mm Hg under 1.1 IOP-lowering medications (mean IOP reduction 
52.1%). In the group with PACG with a history of previous AAC mean IOP was reduced from 29.0 ± 15.7 mm Hg  
under 2.1 IOP-lowering medications to 17.0 ± 7.5 mm Hg under 0.7 IOP-lowering medications (mean IOP 
reduction 41.3%). In the group with PACG without a history of previous AAC (53 eyes) mean IOP was reduced 
from 22.8 ± 8.0 mm Hg under 1.75 IOP-lowering medications to 18.8 ± 7.4 mm Hg under 1.5 IOP-lowering 
medications (mean IOP reduction 17.5%). In all three groups statistically significant improvement of visual acuity 
as a result of surgery was observed. There were no statistically significant differences between the three groups with 
regard to AXL or IOL power. Intraoperative complications were noticed in eight cases, and postoperative compli-
cations were noticed in four cases. The number of anti-glaucoma medications was reduced, but 17 eyes needed 
additional anti-glaucoma procedures.
CONCLUSIONS. Lens extraction in eyes with PACG and PAC resulted in significant IOP reduction in all groups. The 
most pronounced IOP reduction was achieved in the group with PAC, where lens extraction was performed up to 
60 days from AAC. Visual acuity was significantly improved as a result of surgery in all three study groups.
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introduCtion
The World Health Organization ranks glauco-
ma as the second most common cause of blindness 
after cataract and as the leading cause of irrevers-
ible blindness in the world [1]. Although primary 
open-angle glaucoma (POAG) is more common, 
primary angle-closure glaucoma (PACG) is more 
likely to result in severe vision loss. By 2020, 
5.3 million people worldwide will be blind because 
of PACG [2].
Primary angle closure (PAC) is characterised by 
contact between the peripheral iris and the trabec-
ular meshwork (appositional closure) leading to an 
elevated IOP. This contact can ultimately result in 
a permanent synechial closure of the angle. PACG 
occurs when high IOP damages the optic nerve and 
leads to visual loss and, if untreated or inadequately 
treated, causes blindness [3]. There are multiple 
risk factors for angle-closure glaucoma (ACG), in-
cluding hyperopia, short axial length of the eyeball, 
anterior chamber length of less than 2.5 mm, in-
habitant of Eskimo and Southeast Asia, age over 
40 years (due to thickened lens and shallow anterior 
chamber depth), females (because of their tendency 
to have shallower anterior chamber), and a family 
history of ACG [4]. The standard initial ACG treat-
ment is lowering IOP medically, which is followed 
by laser peripheral iridotomy (LPI) relieving pupil 
block, the predominant mechanism of ACG. LPI 
remains the cornerstone of angle-closure manage-
ment; however, long-term IOP control after LPI is 
poor [5]. The main causes of LPI ineffectiveness are 
plateau iris syndrome (PIS), ciliary block, peripher-
al anterior synechiae (PAS) or lens disproportion. 
If the drainage pathway is still closed after LPI, 
alternative laser peripheral iridoplasty is an option. 
If these first-line treatments fail, glaucoma surgery 
(e.g. trabeculectomy) is then indicated. Glaucoma 
surgery may be ineffective to control the IOP, and 
in PACG complications are more likely to develop 
(such as flat anterior chamber and malignant glau-
coma) than for other types of glaucoma [6].
In the 1970s, Bigger and Becker reported a lower 
IOP after cataract extraction in glaucoma patients [7]. 
Since then a new approach to the management of 
patients with PACG (by lens extraction) has gained 
interest among specialists internationally, and many 
investigations have shown variable IOP decrease 
after cataract surgery. 
The aim of this study was to characterise the 
intraocular pressure (IOP) lowering effect of lens re-
moval in eyes with primary angle closure glaucoma 
(PACG) and primary angle closure (PAC). 
MATERIALS AND METHODS
This study is a retrospective analysis of 114 eyes 
of 97 patients (83 women, 14 men) with PACG and 
PAC treated by lens extraction. The effectiveness of 
surgeries performed in the years 2008–2013 in the 
Department of Ophthalmology, Medical Universi-
ty, in Independent Public Clinical Hospital Num - 
ber 1 in Lublin, was analysed. The mean age of par-
ticipants was 70 years (range 50-88 years for women 
and 50-83 years for men), as shown in Table 1. 
Mean follow-up was 408.5 days (± 37.3 SEM) 
(30 days — 6 years). 
The surgical procedure was phacoemulsification 
with intraocular monofocal lens implantation. Prior 
to the surgery, in all eyes laser iridotomy was per-
formed and treatment with anti-glaucoma medica-
tions for IOP lowering was started. 
Patients were divided into three groups (Tab. 2): 
•	 primary angle closure (PAC) (22 eyes) — with 
lens extraction up to 60 days from acute angle 
closure (AAC) (mean 23.3 days, ± 4.5 SEM);
•	 PACG with a history of previous AAC (39 eyes) 
— documented AAC over 60 days prior to lens 
removal (mean 57.5 months, ± 10.2 SEM);
•	 PACG without a history of previous AAC 
(53 eyes).
PAC was defined as iridotrabecular contact of at 
least 180º on gonioscopy, and PACG as reprodu-
cible glaucomatous visual field defects, glaucomatous 
optic neuropathy, or both, and intraocular pressure 
(IOP) greater than 21 mm Hg on at least one visit. 
AAC was defined as: 1) having at least two of these 
symptoms: ocular pain, nausea and/or vomiting, 
Table 1. Basic profile of the patients
Women Men Together
Number of patients 83 (85.6%) 14 (14.4%) 97
Number of eyes 97 (85.1%) 17 (14.9%) 114
Mean age (years) (± SEM) 69.7 (± 1.06) 71.1 (± 2.14 ) 69.9 (± 0.95)
SEM — standard error of the mean
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Table 2. Study groups 
PAC PACG with AAC PACG without AAC
Number of eyes 22 (19.3%) 39 (34.2%) 53 (46.5%)
Mean follow-up (days) (± SEM) 367.5 (± 66.9) 457.3 (± 67.6) 389.6 (± 56.9)
PAC — primary angle closure; PACG — primary angle closure glaucoma; AAC — acute angle closure; SEM — standard error of the mean
Table 3. Best corrected visual acuity (BCVA) results (Wilcoxon signed-rank test; *p < 0.05, **p < 0.01, 
***p < 0.001)
Mean BCVA before  
surgery (± SEM)
Mean BCVA after  
surgery (± SEM)
% improvement
PAC 0.25 ± 0.05 0.54 ± 0.07*** 116.00
PACG with AAC 0.45 ± 0.05 0.59 ± 0.05** 31.11
PACG without AAC 0.44 ± 0.04 0.63 ± 0.04*** 43.18
PAC — primary angle closure; PACG — primary angle closure glaucoma; AAC — acute angle closure; SEM — standard error of the mean
and blurred vision; 2) intraocular pressure of more 
than 21 mm Hg with at least three of these signs: 
corneal epithelial oedema, conjunctival injection, 
non-reactive mid-dilated pupil, and shallow ante-
rior chamber; and 3) the presence of an occluded 
angle in the affected eye, which is proven by go-
nioscopy. Occludable angle closure was defined if 
the posterior trabecular meshwork could not be 
visualised in at least three quadrants.
The main outcome measures were age, gender, 
best corrected visual acuity (BCVA), intraocular 
pressure (IOP) before and after surgery, number 
of glaucoma medications before and after surgery, 
axial length (AXL), intraocular lens (IOL) power, 
additional anti-glaucoma interventions, and intra-
operative and postoperative complications.
Medical data were collected from source doc-
umentation and surgical reports of each patient 
saved by ophthalmological specialists. BCVA 
results were measured with standard Snellen 
charts. IOP was assessed by Goldmann applana-
tion tonometry. To determine the presence and 
severity of glaucomatous neuropathy, visual field 
and optical coherence tomography results were 
evaluated. Standard automated perimetry (SAP) 
using Humphrey Field Analyser was performed for 
the detection of visual field defects. Spectral-do-
main optical coherence tomography (SD-OCT) 
with Cirrus HD-OCT was used for optical disc 
imaging and measurements. Measurement of AXL 
and the IOL power calculations were performed 
using either IOL Master or ultrasound, depending 
on the severity of cataracts and transparency of 
optical centres. Among 114 eyes in six cases clear 
lens extraction was performed (three eyes in PAC 
group and three eyes in PACG with ACC group). 
Before and after surgery anti-glaucoma drugs were 
used. Topical medical treatment and/or systemic 
acetazolamide or mannitol were administrated. 
In cases with uncontrolled glaucoma additional 
procedures were performed.
Statistical analysis was performed to assess the 
results. One-way analysis of variance (ANOVA) was 
used to determine whether there were any statisti-
cally significant differences between the means in 
the three study groups. Additionally, Tukey’s test 
was used to compare and identify any differences 
between results greater than the expected standard 
error. The Wilcoxon signed-rank test was used to 
investigate and estimate changes in the results of 
BCVA, IOP, and the number of anti-glaucoma 
medications during total follow-up. 
RESULTS
In all three groups statistically significant BCVA 
improvement after surgery was observed (Tab. 3). 
The greatest improvement (116%) was found in the 
first group, where lens extraction was performed up 
to 60 days from AAC. 
The analysis of the dataset showed statistically 
significant IOP decrease in all groups after cataract 
surgery (Tab. 4). However, the greatest reduction 
was found in the PAC group (52.26%). Figure 1 
presents the IOP changes in the first year of obser-
vation. Statistical analysis revealed significant differ-
ences in IOP measurements between PAC and other 
groups prior to lens extraction, while there were no 
statistically significant differences continued for an 
observation period of one year after surgery. Intra-
ocular pressure (IOP) results during total follow-up 
are graphically shown in Figure 2. 
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Table 4. Intraocular pressure (IOP) results (Wilcoxon signed-rank test; *p < 0.05, **p < 0.01, 
***p < 0.001)
Mean IOP before  
surgery (± SEM)
Mean IOP after surgery 
(± SEM)
% decrease
PAC 42.27 ± 3.27 20.18 ± 2.21*** 52.26
PACG with AAC 29.69 ± 2.49 17.28 ± 1.19*** 41.80
PACG without AAC 22.74 ± 1.10 18.28 ± 0.93*** 19.61
PAC — primary angle closure; PACG — primary angle closure glaucoma; AAC — acute angle closure; SEM — standard error of the mean
Figure 1. Intraocular pressure (IOP) during the first year of 
follow-up. Vertical bars represent ± standard error of the mean 
(SEM) ANOVA: F(6,93) = 3.8726, p = 0.00171; Post-hoc Tukey’s 
test showed statistically significant differences between PAC and 
other groups before surgery at p < 0.05
The number of anti-glaucoma medication was 
also reduced, but dissimilarity between groups was 
noticed. Statistical analysis revealed a significant 
decrease in the PAC group and the PACG with 
AAC group, but for PACG eyes without a history 
of previous AAC the results were on the border of 
statistical significance. The largest reduction in the 
number of glaucoma medications were found in the 
group with PACG eyes, where cataract surgery was 
performed over 60 days after AAC (Tab. 5).
There were no statistically significant differences 
between the three groups with regard to axial length 
(AXL) or intraocular lens (IOL) power (Tab. 6).
There were intraoperative and postoperative 
complications noted. Posterior capsular rupture and 
vitreous loss were the most common intraopera-
tive complications, found in six cases: one (4.5%) 
in the PAC group , three (7.7%) in the PACG 
with AAC group, and two (3.8%) in the PACG 
without AAC group. During phacoemulsification 
in one (1.9%) eye from the PACG without ACC 
group, intraoperative floppy iris syndrome (IFIS) 
was reported. Other intraoperative complication 
was Descemet’s membrane detachment found in 
one (2.6%) eye with PACG where lens removal was 
performed over 60 days after AAC. Postoperative 
complications were noticed in four cases. Malig-
nant glaucoma was the most frequent postoperative 
complication diagnosed in one (4.5%) eye from the 
PAC group and two (3.8%) eyes from the PACG 
without AAC group. In the PACG without AAC 
group one (1.9%) eye developed bullous kerato-
pathy. All complications were treated in accordance 
with applicable standards.
Additional anti-glaucoma procedures were need-
ed in 17 eyes. Trabeculectomy was the most frequent 
procedure, performed in six (11.3%) eyes from the 
PACG without AAC group, two (9%) eyes from 
the PAC group, and only one (2.6%) eye from the 
PACG with AAC group. Vitrectomy and iridec-
tomy with zonulectomy as a malignant glaucoma 
treatment was reported in two (3.8%) eyes from the 
PACG without AAC group and one (4.5%) eye from 
the PAC group. Other additional interventions were 
cyclophotocoagulation and goniosynechiolisis. Cy-
clophotocoagulation was noted in three eyes — one 
(4.5%) in the PAC group and two (5.1%) in the 
PACG with AAC group. Goniosynechiolisis was re-
ported in two eyes — one (4.5%) in the PAC group 
and one (2.6%) in the PACG with AAC group. 
disCussion
Standard approach to the patient with primary 
AAC is a stepped combination of medical and laser 
therapy. Glaucoma surgery is indicated as a sec-
ond-line option when these treatments fail. How-
ever, recently cataract extraction is more often con-
sidered for primary AAC management. 
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Figure 2. Intraocular pressure (IOP) during total follow-up; Median (percentile 25–75); whisker: non-outlier range; PAC — primary angle 
closure; PACG — primary angle closure glaucoma; AAC — acute angle closure
Table 5. Number of glaucoma medications (Wilcoxon signed-rank test; *p < 0.05, **p < 0.01, ***p < 0.001)
Mean number of glaucoma medications 
before surgery (± SEM)
Mean number of glaucoma medications 
after surgery (± SEM)
% decrease
PAC 2.63 ± 0.31 1.09 ± 0.25** 58.55
PACG with AAC 2.11 ± 0.21 0.77 ± 0.19*** 63.56
PACG without AAC 1.83 ± 0.17 1.57 ± 0.18 14.43
PAC — primary angle closure; PACG — primary angle closure glaucoma; AAC — acute angle closure; SEM — standard error of the mean
Table 6. Axial length and intraocular lens power
PAC PACG with AAC PACG without ACC  p
Mean axial length (AXL)[mm] 
(± SEM)1
21.9 ± 0.19 21.6 ± 1.17 21.7 ± 0.19 > 0.05
Mean intraocular lens power 
(IOL) [D] (± SEM)2
25.8 ± 0.44 25.7 ± 0.34 25.2 ± 0.33 > 0.05
1ANOVA: F(2,103) = 0.61; p = 0.54; 2ANOVA: F(2,111) = 0.88; p = 0.42
PAC — primary angle closure; PACG — primary angle closure glaucoma; AAC — acute angle closure; SEM — standard error of the mean
Pupillary block is the most common cause of 
ACC. Laser peripheral iridotomy is a gold standard 
for interrupting this configuration. However, the 
Liwan Eye Study showed that among eyes identi-
fied as primary closure angle suspects (PACS), LPI 
resulted in a significant increase in the angle width, 
but about one fifth of eyes had residual angle clo-
sure based on gonioscopy two weeks after the LPI. 
Quantitative assessment of the angle using UBM 
demonstrated that residual angle closure tended to 
occur in eyes with smaller anterior chamber angle 
dimensions, a thicker and more anteriorly inserted 
iris, and a more anterior positioned ciliary body [8]. 
Another study demonstrated that among patients 
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with persistent occludable angles, the most common 
underlying mechanisms were plateau iris and lens-in-
duced component [9]. PACG eyes have significantly 
thicker lens, with a steeper anterior surface, which 
is more often anteriorly positioned when compared 
with controls [10]. Thick lens usually increases pu-
pillary block and consequent angle closure. Removal 
of the lens allows anterior chamber deepening and 
angle widening, which results in increasing the hu-
mour outflow and IOP reduction. These biometrical 
changes are more pronounced in ACG patients than 
in OAG patients or the control group [11]. 
IOP decrease may be also associated with other 
mechanisms. Poley et al. suggest that lens removal 
allows the posterior capsule to move posteriorly, 
dislodging the zonula over the ciliary body with 
a consequent widening of Schlemm’s canal and 
aqueous humour drainage improvement [12]. An-
other theory suggests that ultrasound energy used 
for phacoemulsification procedure is responsible for 
a sudden rise of pressure in the anterior chamber, 
producing inflammatory cytokines (mostly IL-1) 
that stimulate metalloproteinase production and 
trabecular meshwork remodelling, facilitating hu-
mour drainage [13]. 
Comparison of LPI and phacoemulsification re-
vealed better long-term IOP control after resolving 
acute angle closure crisis with lens extraction. Fur-
ther advantages were reduced need for long-term 
medication in order to maintain an optimal IOP, 
wider angle and fewer PAS formation, with a small-
er risk of a second angle closure crisis or progression 
to chronic angle closure, which is approximately 
58.1% after LPI [5, 14]. Also, when IOP at the 
base line is higher than 55 mm Hg (which is an 
independent risk factor of long-term uncontrolled 
IOP), patients are less likely to require IOP-lower-
ing therapy if treated with early cataract extraction, 
when comparing with LPI [14]. Phacoemulsifica-
tion is, however, a more dangerous procedure due 
to the risk of shallow anterior chamber, possibility 
of endothelium damage and atonic iris [15]. In our 
retrospective study eight intraoperative and four 
postoperative cases of complications were noted. 
The most frequent complication (five eyes) was pos-
terior capsule rupture, which is also the most com-
mon complication during cataract surgery, reported 
with similar frequency in other studies [16]. Post-
operative malignant glaucoma (diagnosed in three 
study eyes) is a pathological condition, the higher 
incidence is associated with a narrow or closed an-
gle, shallow anterior chamber, and hyperopia [17].
When the anterior chamber angle is chronically 
closed by peripheral anterior synechiae (PAS) com-
bined phacoemulsification and goniosynechialysis is 
a preferred method in treating ACG with concom-
itant cataract. It is considered as a reasonable, high-
ly effective, and safe procedure [18]. Depending 
on the degree of angle closure, different approach-
es are recommended. Phacoemulsification alone 
might be more suitable for ACG eyes with angle 
closure < 180°, combined phaco-goniosynechialiysis 
might be more suitable for ACG eyes with angle 
closure of 180~270°, and combined phaco-trabe-
culectomy might be more suitable for ACG eyes 
with angle closure > 270° [19]. 
Clear lens extraction in eyes with AAC is still 
under debate. In our retrospective study it was per-
formed in six among 114 cases (three eyes in the 
PAC group and three eyes in the PACG with ACC 
group). With good visual acuity LPI appears to have 
a better risk-to-benefit ratio. Nevertheless, in select-
ed cases, lens extraction may be a better option for 
IOP control. To help clarify this matter the EAGLE 
trial was designed. This multicentre prospective ran-
domised clinical trial compared clear-lens extraction 
and standard care with LPI and topical medical 
treatment in patients with newly diagnosed primary 
angle-closure and primary angle closure glaucoma. 
The co-primary endpoints were patient-report-
ed health status, intraocular pressure, and incre-
mental cost-effectiveness ratio per quality-adjusted 
life-gained 36 months after treatment. The results 
showed that clear lens extraction had greater effi-
cacy and was more cost-effective, especially over 
the long term. Significantly fewer patients in this 
group needed any treatment to control IOP and 
fewer needed glaucoma medications than patients 
who received standard care. The authors suggested 
that clear lens extraction should be considered as 
an option for first-line treatment [20]. Economic 
findings from the EAGLE study indicated that lens 
extraction has a 67–89% chance of being cost ef-
fective at three years (fewer subsequent procedures 
including repeat LPI, lens extraction or glaucoma 
surgery, and lower medication use), and it may be 
cost saving by 10 years [21]. 
In another study, Tham et al. confronted 
phacoemulsification and trabeculectomy in primary 
ACG patients with clear lens. Both procedures were 
effective in reducing IOP (reduction of 34% for 
phacoemulsification vs. 36% for trabeculectomy). 
Trabeculectomy-treated patients seemed to be less 
dependent on the additional anti-glaucoma medica-
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tions than phacoemulsification-treated patients, but 
at the same time trabeculectomy was associated with 
significantly more surgical complications (46 vs. 4%), 
and cataract formation was the most frequent of 
them in long-term observation (33%) [22].
CONCLUSIONS
Lens extraction in eyes with PAC and PACG re-
sulted in significant IOP reduction in all groups. The 
biggest IOP reduction was achieved in the group 
with PAC, where lens extraction was performed 
up to 60 days from AAC. BCVA was significantly 
improved in all three groups as a result of surgery. 
There were no statistically significant differences be-
tween the three groups with regard to AXL or IOL 
power. Intraoperative complications were noticed in 
eight cases, and postoperative complications were 
noticed in four cases. The number of anti-glaucoma 
medications was reduced, but 17 eyes needed addi-
tional anti-glaucoma procedures.
Lens extraction by phacoemulsification with 
IOL implantation could be an effective method of 
treatment in PACG patients, but further long-term 
prospective studies are needed to fully evaluate their 
efficacy. 
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